A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of ISIS 546254 for Preventive Treatment of Chronic Migraine
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 11 Sep 2018
At a glance
- Drugs IONIS PKKRx (Primary)
- Indications Migraine
- Focus Adverse reactions; Therapeutic Use
- 04 Sep 2018 Status changed from recruiting to active, no longer recruiting.
- 16 Apr 2018 Planned End Date changed from 31 Dec 2017 to 31 Dec 2018.
- 16 Apr 2018 Planned primary completion date changed from 31 Dec 2017 to 31 Dec 2018.